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Abstract We have previously shown that in N I H 3T3 
fibroblasts phosphocholine (PCho) potentiates sphingosine-1-
phosphate (SI P)-induced mitogenesis. Here we report that PCho 
and S I P also synergistically stimulate DNA synthesis in mouse 
Swiss 3T3 fibroblasts and in mouse JB6 epidermal cells. The 
combined actions of PCho and S I P on DNA synthesis were 
associated with synergistic activation of the p42/p44 mitogen-
activated protein (MAP) kinases. Ethanolamine (50-100 (iM) 
further enhanced the synergistic effects of PCho and S I P on 
DNA synthesis but not on MAP kinase activity. The results 
indicate that the synergistic mitogenic effects of PCho and S I P 
(i) are not restricted to N I H 3T3 fibroblasts, (ii) are 
predominantly mediated by the MAP kinase-dependent signal 
transduction pathway, and (iii) are enhanced by ethanolamine via 
a MAP kinase-independent mechanism. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Phosphocholine (PCho), an intermediate of phosphatidyl-
choline biosynthesis, has recently been shown by others [1,2] 
and by us [3-5] to stimulate D N A synthesis in N I H 3T3 
fibroblast cultures. These findings, coupled with other obser-
vations that PCho levels are regulated by growth factors [6], 
oncogenes [7-9], and chemical carcinogens [10-12], suggest 
that PCho may be involved in the regulation of cell growth, 
and perhaps in carcinogenesis, in vivo. It is, therefore, impor-
tant to determine how widespread the growth regulatory ef-
fects of PCho are, and which signal transduction mechanisms 
are involved. 
Work in our laboratory has so far established that in N I H 
3T3 fibroblasts PCho acts on mitogenesis through an extra-
cellular site, and that its relatively small effect on D N A syn-
thesis is greatly potentiated by ATP, insulin, or sphingosine-1 -
phosphate (SIP) [5]. While the combined effects of PCho and 
A T P as well as PCho and insulin appeared to be predomi-
nantly mediated by a pp70 S6 kinase-dependent mechanism 
[5], the signal transduction pathway mediating the combined 
effects of PCho and S I P remained to be clarified. Thus, an 
important goal of this work was to determine the mechanism 
of combined mitogenic actions of PCho and SIP . 
The overall significance of the observed mitogenic effects of 
PCho depends on, among others, how widespread these effects 
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r - , T , are. Accordingly, another important goal was to test the pos-
sine-1- s ^ ' e s y n e r g i s t i c mitogenic effects of PCho and S IP in addi-
PCho tional cell lines. For this purpose, in this study we chose Swiss 
se 3T3 fibroblasts and JB6 epidermal cells. It was of interest to 
examine Swiss 3T3 fibroblasts, because the mitogenic effect of 
  S IP on D N A synthesis was first detected in this cell line 
itogen- [13,14]. JB6 cells were chosen because we have a parallel on-
9 (lM) going investigation in this laboratory testing the role of PCho 
I P on j n i n d e e d transformation of these cells. Our data show that 
results p c h o a n d S l p e x e r t s v n e r g j s t i c stimulatory effects on D N A 
.* synthesis in both Swiss 3T3 fibroblasts and JB6 cells. Further-
1) are 
• 1 more, we demonstrate that the mitogenic actions of PCho and 
evi  ^1P are associated with synergistic activation of the p42/p44 
M A P kinases. 
2. Materials and methods 
2.1. Materials 
PCho and ethanolamine were purchased from Sigma; SIP was 
bought from Biomol; the MAP kinase assay kit was obtained from 
New England Biolabs; and [rae;/2j>/-3H]thymidine (85 Ci/mmol) was 
purchased from Amersham. 
atldyl- 2.2. Cell lines 
'S [ , ] The promotion-sensitive JB6 clone-41 cell line was kindly supplied 
1  by Dr. Nancy H. Colburn (National Institutes of Health, Frederick, 
obser- M D ' U S A ) ; t h e N I H 3 T 3 clone-7 cell line was donated by Dr. Doug-
rffl las R. Lowy (National Institutes of Health, Bethesda, MD, USA); 
L " and the Swiss 3T3 cell line was from the American Type Culture 
uggest Collection (Rockville, MD, USA). Each cell line was continuously 
ro th, cultured in Dulbecco's modified Eagle's medium supplemented with 
r- lO''0 (v 'v) fetal calf serum, penicillin/streptomycin/neomycin (50 |ig/ml, 
ef "*" |J.g/ml and 100 ug/ml, respectively) and glutamine (2 mM). 
imsms 2.3. Labeling of cellular DNA with [ 3H]thymidine 
In each case, cells were grown in 12-well tissue culture dishes to 
l I  about 40% confluence in the presence of 10% serum, washed, and then 
extra- incubated in serum-free medium for 24 h. Cells (-80% confluent) were 
. washed again and then treated (in serum-free medium) for 16 h with 
" PCho and/or SIP in the absence or presence of ethanolamine as in-
sme-1- dicated in the text. SIP was added 10 min prior to PCho, while PCho 
10  and ethanolamine were added to the medium simultaneously. Finally, 
i i- incubations were continued in the presence of [me^y/-3H]thymidine 
• (1.0 uCi/well) for 60 min. The cells were washed twice with phosphate-
buffered saline, then four times with 5% trichloroacetic acid, and 
mea finally twice with absolute ethanol. The acid-insoluble material was 
us, an redissolved in 0.3 M sodium hydroxide, and an aliquot was taken to 
l  measure DNA-associated 3H activity in a liquid scintillation counter. 
„ 2.4. Determination of MAP kinase activity 
This was performed as described previously [5]. Briefly, serum-
enects starved NIH 3T3 cells in 6-well tissue culture dishes were first treated 
for 10 min with SIP, and then for 15 min with PCho (in the contin-
uous presence of SIP) in the absence or presence of ethanolamine as 
indicated in the legend to Fig. 4. The activity state of MAP kinase was 
determined by immunoblot analysis [5]. The phosphospecific MAP 
 kinase antibody used here recognizes the tyrosine 204 phosphorylation 
site in the activated forms of p42 and p44 MAP kinases. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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3. Results and discussion 
3.1. Mitogenic effects of PCho and SIP in Swiss 3T3 and JB6 
cells 
Both in serum-starved Swiss 3T3 cells (Fig. 1A) and JB6 
cells (Fig. IB), 5 (iM SIP appreciably stimulated DNA syn-
thesis, but the rate of SIP-stimulated incorporation of radio-
labeled thymidine into DNA was only about 10% of that 
observed upon readdition of 10% serum (not shown). Simi-
larly, PCho alone, even when added at a maximally effective 
concentration (1 mM), had only very small effects on DNA 
synthesis in both cell lines. However, both in Swiss cells (Fig. 
1A) and JB6 cells (Fig. IB) PCho was able to greatly enhance 
SIP-induced DNA synthesis, and to sensitize the cells to the 
actions of lower concentrations of SIP. Thus, in PCho-treated 
cells SIP at a concentration as low as 0.25 (iM became a 
potent inducer of DNA synthesis. Importantly, in the pres-
ence of PCho the mitogenic effect of 5 uM SIP was roughly 
equivalent with that of 10%> serum. 
For a comparison, we also determined the combined effects 
of SIP and PCho on DNA synthesis in NIH 3T3 cells (Fig. 
1C). Of the three cell lines examined, SIP and PCho, both 
alone and in combination, had the largest mitogenic effects in 
NIH 3T3 cells (Fig. 1C compared to Fig. 1A and B). How-
ever, in additional experiments we found that in comparison 
to the two other cell lines, in NIH 3T3 cells serum was also 
about twice more effective in stimulating DNA synthesis. Tak-
ing all these findings into account, it seems fair to conclude 
that PCho and SIP have comparable synergistic effects on 
DNA synthesis in the three cell lines used in these experi-
ments. 
At an optimal (5 uM) concentration of SIP, 0.25 mM PCho 
detectably enhanced the mitogenic effect of SIP in both Swiss 
3T3 cells (Fig. 2A) and JB6 cells (Fig. 2B). Maximal potenti-
ating effects required 1 mM PCho; elevation of PCho concen-
tration to 2 mM failed to yield larger effects. 
3.2. Potentiation of the combined stimulatory effects of PCho 
and SIP by ethanolamine 
Ethanolamine is present in the blood at concentrations 
ranging from 5 to 50 |0.M in various species ([15], and refer-
ences therein), which can be further enhanced under certain 
conditions, including liver regeneration [15] and renal failure 
[16]. In addition, phospholipase D-mediated hydrolysis of 
phosphatidylethanolamine, which has been shown to be 
stimulated by several agents in numerous cell types (reviewed 
in ref. [17]), is also likely to elevate ethanolamine levels in the 
extracellular space. For these reasons, it was of interest to 
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Fig. 1. PCho and SIP synergistically stimulate DNA synthesis in Swiss 3T3, JB6, and NIH 3T3 cells. Serum-starved (24 h) Swiss 3T3 (A), JB6 
(B) and NIH 3T3 (C) cells were treated for 16 h with 0-5 uM concentrations of SIP in the absence (•) or presence ( A ) of 1 mM PCho, fol-
lowed by incubation in the presence of [merAr</-3H]thymidine for 1 h. Each point represents the mean±S.D. (« = 6). Similar results were ob-
tained in two other experiments each performed in triplicate. 
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Fig. 2. Concentration-dependent effect of PCho on SlP-induced DNA synthesis in Swiss 3T3 and JB6 cells. Serum-starved Swiss 3T3 (A) and 
JB6 (B) cells were treated for 16 h with 0-1 mM concentrations of PCho in the absence (•) or presence ( A ) of 5 uM SIP, followed by incuba-
tion in the presence of [rae;/i)>/-3H]thymidine for 1 h. Each point represents the mean ± S.D. (n - 3). Similar results were obtained in two other 
experiments each performed in triplicate. 
determine how ethanolamine might affect the combined stim-
ulatory effects of SIP and PCho on DNA synthesis. As shown 
in Fig. 3, addition of ethanolamine at 50 and 100 uM con-
centrations to NIH 3T3 cells further enhanced the synergistic 
mitogenic effects of PCho and SIP even when SIP was used at 
a maximally effective (5 U.M) concentration. Ethanolamine 
had no potentiating effects when used at 20 |iM concentra-
tion, and its effects were not further enhanced by elevating its 
concentration above 100 uM. When 1 mM PCho and 5 uM 
SIP were added alone, 100 |xM ethanolamine enhanced only 
the effect of PCho (about 3-fold; data not shown). 
3.3. Combined effects of PCho and SIP on MAP kinase 
activity 
Possible activation of p42/p44 MAP kinases (also known as 
extracellular signal-regulated kinases, or ERKs) by SIP and 
PCho was examined in NIH 3T3, because these agents had 
the largest effects on DNA synthesis in this cell line. A pre-
vious study has demonstrated that in Swiss 3T3 cells SIP 
alone can detectably stimulate MAP kinase activity [18]. As 
shown in Fig. 4, in NIH 3T3 fibroblasts as well 0.5 and 5 uM 
concentrations of SIP alone induced relatively weak, but de-
tectable, activation of MAP kinase (Fig. 4). Similarly, PCho 
alone had only a small effect on MAP kinase activity. How-
ever, simultaneous treatments of cells with SIP (0.5 or 5 |a.M) 
and PCho resulted in strong activation of MAP kinase (Fig. 
4). Interestingly, the combined effects of SIP and PCho on 
MAP kinase activity were not enhanced by ethanolamine (Fig. 
4), despite the ability of ethanolamine to increase the syner-
gistic effects of SIP and PCho on DNA synthesis (Fig. 3). It 
still should be noted that 0.5 and 5 |j.M concentrations of SIP 
were equally effective in stimulating MAP kinase activity (Fig. 
4), although in the experiment shown in Fig. 1 maximal stim-
ulation of DNA synthesis required 5 iiM SIP. The only ex-
planation we can offer to explain this apparent discrepancy is 
that maximal stimulation of DNA synthesis may require the 
presence of SIP for a longer than 15 min period (the length of 
incubation time used for the MAP kinase assay). Since SIP is 
known to be metabolically unstable, in case of DNA synthesis 
assay a higher starting concentration of SIP may be needed. 
In conclusion, we showed that in each of the three cell lines 
examined here, simultaneous treatments with maximally effec-
Fig. 3. Potentiating effect of ethanolamine on PCho plus SlP-in-
duced DNA synthesis in NIH 3T3 fibroblasts. Serum-starved NIH 
3T3 fibroblasts were incubated for 16 h in the presence of 1 mM 
PCho plus 0.5 uM SIP (□) or PCho plus 5 uM SIP (■) in the ab-
sence (I) or presence of 50 uM ethanolamine (II) or 100 |xM etha-
nolamine (III). Data are the mean ± S.D. (n = 6). Similar results 
were obtained in three other experiments each performed in tripli-
cate. 
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Fig. 4. Synergistic stimulation of MAP kinase activity by PCho and 
SIP in NIH 3T3 cells. Serum-starved cells were first treated with 
SIP for 10 min, followed by incubations in the presence of 1 mM 
PCho and 100 uM ethanolamine for an additional 15 min period as 
indicated. Additions were as follows: none (lane 1), 0.5 uM SIP 
(lane 2), 5 uM SIP (lane 3), PCho (lane 4), 0.5 |xM SIP plus PCho 
(lane 5), 5 uM SIP plus PCho (lane 6), 0.5 uM SIP plus PCho plus 
ethanolamine (lane 7), 5 uM SIP plus PCho plus ethanolamine 
(lane 8). Lane 9 represents the MAP kinase standard. The lower 
and upper bands represent the p42 and p44 MAP kinases, respec-
tively. 
tive concentrations of SIP and PCho induced DNA synthesis 
to about the same level as 10% serum. In contrast, both 
agents were poor mitogens when applied alone. These data 
indicate that synergistic stimulation of DNA synthesis by 
SIP and PCho is not restricted to NIH 3T3 cells; in fact, 
these agents in combination may be part of a widespread 
regulatory mechanism. Interestingly, two previous studies im-
plicated, separately, both PCho [1] and SIP [19] in the medi-
ation of mitogenic effects of certain growth factors, including 
platelet-derived growth factor and fibroblast growth factor. 
Our results now suggest that PCho and SIP can serve as 
effective mediators of the growth factor effects only if they 
act simultaneously. Considering that (i) PCho acts through 
an extracellular target [5], (ii) cells express receptors for SIP 
[20-22], and (iii) SIP (being a phosphate-containing com-
pound) may not be taken up by the cells efficiently, it seems 
likely that both compounds need to be released from cells for 
their mitogenic actions to occur. This possibility is presently 
being studied in our laboratory. 
SIP and PCho also synergistically activated the p42/p44 
MAP kinases. This suggests that these enzymes play an im-
portant role in the mediation of mitogenic effects of SIP and 
PCho. Interestingly, ethanolamine was able to further increase 
the synergistic effects SIP and PCho on DNA synthesis, but 
not on MAP kinase activity. This indicates that the mitogenic 
activities of SIP and PCho can be enhanced by a MAP kin-
ase-independent mechanism. The experiments with ethanol-
amine also suggest the interesting possibility that activation 
of phosphatidylethanolamine-specific phospholipase D [18] 
may lead to the potentiation of mitogenic effects of SIP and 
PCho. This possibility as well as the physiological significance 
of the synergistic mitogenic effects of SIP and PCho remains 
to be determined. 
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